Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -84.99%652.42M | -49.76%1.99B | -45.82%957.73M | -30.11%1.38B | 133.96%4.35B | 60.24%3.95B | -23.09%1.77B | 7.20%1.98B | -22.69%1.86B | -15.53%2.47B |
Transactional financial assets | 2,499.57%520.82M | 8.56%760.18M | --1.66B | --2.58B | --20.03M | --700.27M | ---- | ---- | ---- | ---- |
Notes receivable and accounts receivable | 49.08%809.69M | -51.23%314.05M | 10.37%606.45M | -20.26%521.22M | -27.70%543.12M | -15.90%643.92M | 3.25%549.49M | 20.03%653.68M | 60.62%751.23M | 60.16%765.64M |
-Notes receivable | 328.66%2.19M | --9.45M | --1.4M | --485.55K | --511.1K | ---- | ---- | ---- | ---- | --26.6K |
-Accounts receivable | 48.82%807.5M | -52.70%304.6M | 10.11%605.05M | -20.34%520.74M | -27.77%542.61M | -15.89%643.92M | 3.25%549.49M | 20.05%653.68M | 60.62%751.23M | 60.16%765.61M |
Other receivables (including interest and dividends) | -20.57%16.21M | -26.36%19.25M | -37.17%19.54M | -19.95%19.69M | -17.93%20.4M | -13.31%26.14M | -1.75%31.11M | -20.30%24.59M | -20.49%24.86M | -0.01%30.16M |
-Other receivable | ---- | -26.36%19.25M | ---- | -19.95%19.69M | ---- | -13.31%26.14M | ---- | -20.30%24.59M | ---- | -0.01%30.16M |
Contractual assets | -48.41%19.99M | -49.60%19.99M | -13.98%38.47M | -13.90%38.51M | -13.57%38.74M | -12.98%39.65M | 25.02%44.73M | 24.67%44.73M | 29.02%44.82M | 26.55%45.57M |
Advance payment | 375.16%973.33M | 423.59%774.38M | 543.95%854.38M | 7,167.02%550.43M | 2,388.42%204.84M | 1,687.21%147.9M | -25.33%132.68M | -91.62%7.57M | -92.23%8.23M | -90.29%8.28M |
Inventories | 2,037.76%2.76B | 1,684.66%1.77B | 310.85%1.02B | 7.39%235.43M | -51.17%128.88M | -65.38%99.4M | -41.24%247.09M | -40.47%219.22M | -24.37%263.95M | 0.03%287.12M |
Other current assets | 336.15%200.79M | 316.19%152M | -96.34%109.98M | -96.83%70.96M | -94.85%46.04M | -94.39%36.52M | 84.50%3B | -9.49%2.23B | -62.87%893.14M | -72.10%651.09M |
Total current assets | 11.19%5.95B | 2.71%5.8B | -9.00%5.26B | 4.61%5.4B | 39.15%5.35B | 32.72%5.65B | 12.74%5.78B | -4.12%5.16B | -33.69%3.84B | -31.04%4.26B |
Non Current assets | ||||||||||
Other debt investment | -29.43%50.76M | -29.31%50.46M | -29.20%50.16M | ---- | -88.25%71.93M | -88.24%71.39M | --70.84M | --687.58M | --612.1M | --606.98M |
Other non-current financial assets | 0.00%9.35M | 0.00%9.35M | 0.00%9.35M | 27.21%9.35M | 27.21%9.35M | 27.21%9.35M | 27.21%9.35M | 0.00%7.35M | 0.00%7.35M | 0.00%7.35M |
Fixed assets | ---- | 63.22%231.43M | ---- | -37.81%114.83M | ---- | -39.21%141.78M | ---- | -26.85%184.66M | ---- | -16.68%233.24M |
Constru in process | ---- | 37.62%150.23M | ---- | 145.78%138.93M | ---- | 317.28%109.16M | ---- | 543.63%56.53M | ---- | 2,372.01%26.16M |
Intangible assets | 14.61%154.38M | 21.90%182.76M | -27.17%128.46M | -42.54%122.89M | -46.55%134.7M | -48.50%149.93M | -43.82%176.38M | -30.09%213.85M | -5.57%252.01M | 11.54%291.15M |
Long deferred expense | 1,031.07%29.06M | 168.28%15.02M | -45.09%3.61M | -81.54%1.8M | -80.21%2.57M | -64.48%5.6M | -38.15%6.58M | 8.39%9.73M | 29.31%12.99M | 27.31%15.76M |
Deferred tax assets | -59.66%31.55K | -86.00%40.94K | -25.67%46.14K | -41.21%36.49K | 25.97%78.2K | -37.01%292.35K | 1,892.46%62.08K | 1,892.46%62.08K | 1,892.46%62.08K | 14,796.83%464.12K |
Usufruct assets | -42.07%13.47M | -61.52%15.71M | -64.88%22.8M | -63.34%30.13M | -76.80%23.26M | -61.36%40.83M | -41.17%64.93M | 33.14%82.19M | 26.17%100.24M | 8.50%105.67M |
Other non current assets | 194.85%76.06M | 25.91%15.9M | 1,341.06%70.04M | 1,317.24%74.17M | 369.12%25.8M | 89.32%12.63M | -82.28%4.86M | -90.14%5.23M | -86.76%5.5M | -76.95%6.67M |
Total non current assets | 32.15%996.55M | 19.08%917.5M | 4.20%837.52M | -49.72%738.92M | -48.48%754.11M | -49.16%770.52M | -8.99%803.8M | 75.21%1.47B | 79.44%1.46B | 85.21%1.52B |
Total assets | 13.78%6.94B | 4.67%6.72B | -7.39%6.09B | -7.43%6.14B | 14.99%6.1B | 11.22%6.42B | 9.54%6.58B | 6.57%6.63B | -19.74%5.31B | -17.43%5.77B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | --100.09M | --100.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Notes payable and accounts payable | 172.37%509.87M | 116.94%514.64M | 127.25%329.44M | 53.59%205.47M | 10.26%187.2M | 2.94%237.23M | -29.68%144.97M | -2.40%133.78M | 32.05%169.78M | 7.35%230.44M |
-Accounts payable | 172.37%509.87M | 116.94%514.64M | 127.25%329.44M | 53.59%205.47M | 10.26%187.2M | 2.94%237.23M | -29.68%144.97M | -2.40%133.78M | 32.05%169.78M | 7.35%230.44M |
Contract liabilities | 12.38%1.42M | 236.48%886.17K | -99.68%747.74K | --625.72K | --1.27M | 93.25%263.36K | 646,225.75%233.91M | ---- | ---- | -40.74%136.28K |
Salaries payable | -67.84%38.64M | -2.08%156.24M | -28.70%34.61M | -21.68%34.52M | -20.56%120.15M | -20.08%159.55M | -12.63%48.54M | -15.39%44.07M | -11.41%151.26M | 4.08%199.63M |
Taxs payable | 134.26%51.82M | -9.28%26.78M | -88.78%4.66M | -73.35%8.59M | -23.10%22.12M | -34.01%29.52M | 136.59%41.56M | 126.53%32.23M | -4.28%28.76M | 11.83%44.74M |
Other payable (including interest and dividends) | -89.51%68.56K | 398.32%7.01M | -82.82%174.85K | 1.64%3.06M | 2,837.43%653.64K | -66.82%1.41M | 848.50%1.02M | 497.74%3.01M | -67.88%22.25K | 69.43%4.24M |
-Other payable | ---- | 398.32%7.01M | ---- | 1.64%3.06M | ---- | -66.82%1.41M | ---- | 497.74%3.01M | ---- | 69.43%4.24M |
Non current liabilities due within one year | -60.36%8.42M | -64.61%12.45M | -65.78%18.84M | -59.81%26.33M | -68.72%21.23M | -44.12%35.18M | -7.51%55.05M | 117.70%65.52M | 69.31%67.88M | 17.89%62.94M |
Other current liabilities | -35.78%105.83K | 4.63%35.82K | -38.58%17.83K | --1.96K | --164.8K | 93.25%34.24K | 900.03%29.02K | ---- | ---- | 2,649.95%17.72K |
Total current liabilities | 101.38%710.43M | 76.63%818.14M | -26.01%388.5M | -0.01%278.6M | -15.54%352.79M | -14.57%463.18M | 54.92%525.08M | 19.03%278.62M | 12.47%417.71M | 7.87%542.14M |
Current liabilities | ||||||||||
Deferred tax liabilities | 90.19%387.12K | -27.29%268.44K | --342.5K | --260.5K | --203.55K | -26.31%369.19K | ---- | ---- | ---- | --501K |
Long term deferred income | 96.94%394.77M | 112.52%467.16M | 232.19%557.26M | 193.19%558.28M | -5.95%200.46M | -10.92%219.82M | -52.39%167.75M | -51.98%190.41M | -49.61%213.14M | -46.89%246.76M |
Lease liabilities | 173.72%3.42M | -65.60%1.77M | -74.88%2.06M | -83.31%2.4M | -96.06%1.25M | -87.68%5.14M | -83.79%8.2M | -51.09%14.36M | -9.19%31.73M | -0.06%41.69M |
Total non current liabilities | 97.41%398.58M | 108.23%469.2M | 218.08%559.66M | 173.93%560.93M | -17.54%201.91M | -22.02%225.33M | -56.33%175.95M | -51.92%204.77M | -46.53%244.87M | -42.93%288.96M |
Total liabilities | 99.93%1.11B | 86.97%1.29B | 35.25%948.16M | 73.67%839.54M | -16.28%554.7M | -17.16%688.51M | -5.50%701.03M | -26.75%483.4M | -20.11%662.57M | -17.63%831.1M |
Shareholders equity | ||||||||||
Paid-in capital | 0.21%417.46M | 0.21%417.46M | 0.21%417.46M | 0.00%416.59M | 3.94%416.59M | 3.94%416.59M | 3.94%416.59M | 3.94%416.59M | 0.00%400.81M | 0.18%400.81M |
Capital reserve funds | 2.34%9.86B | 2.42%9.81B | 1.12%9.8B | 0.19%9.69B | 22.02%9.63B | 21.63%9.58B | 22.98%9.69B | 23.57%9.67B | 2.47%7.9B | 3.52%7.87B |
Retained profit | 2.92%-4.32B | -10.72%-4.67B | -18.31%-4.95B | -21.29%-4.75B | -22.61%-4.45B | -25.16%-4.22B | -36.58%-4.18B | -43.06%-3.92B | -50.94%-3.63B | -59.40%-3.37B |
Less:Treasury stock | 0.00%130.29M | 5.86%130.29M | 12.25%130.29M | 30.21%130.29M | 30.21%130.29M | 158.50%123.08M | 211.10%116.08M | 255.42%100.06M | --100.06M | --47.61M |
Shareholders equity without minority interests | 6.51%5.83B | -4.02%5.42B | -11.54%5.14B | -13.93%5.22B | 19.78%5.47B | 16.37%5.65B | 12.11%5.81B | 11.17%6.07B | -19.88%4.57B | -17.59%4.85B |
Minority interests | -90.19%7.58M | -90.19%7.82M | -88.31%8.38M | -4.02%76.47M | 0.14%77.32M | -6.06%79.69M | -15.78%71.69M | -23.27%79.67M | -5.98%77.21M | -4.96%84.83M |
Total shareholder equity | 5.17%5.84B | -5.22%5.43B | -12.48%5.15B | -13.80%5.3B | 19.45%5.55B | 15.99%5.73B | 11.66%5.88B | 10.52%6.15B | -19.69%4.65B | -17.40%4.94B |
Total liabilityies and equity | 13.78%6.94B | 4.67%6.72B | -7.39%6.09B | -7.43%6.14B | 14.99%6.1B | 11.22%6.42B | 9.54%6.58B | 6.57%6.63B | -19.74%5.31B | -17.43%5.77B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.